These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 24594678)

  • 1. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.
    Gasser P; Holstein D; Michel Y; Doblin R; Yazar-Klosinski B; Passie T; Brenneisen R
    J Nerv Ment Dis; 2014 Jul; 202(7):513-20. PubMed ID: 24594678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects.
    Gasser P; Kirchner K; Passie T
    J Psychopharmacol; 2015 Jan; 29(1):57-68. PubMed ID: 25389218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
    Holze F; Gasser P; Müller F; Dolder PC; Liechti ME
    Biol Psychiatry; 2023 Feb; 93(3):215-223. PubMed ID: 36266118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.
    Wolfson PE; Andries J; Feduccia AA; Jerome L; Wang JB; Williams E; Carlin SC; Sola E; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Sci Rep; 2020 Nov; 10(1):20442. PubMed ID: 33235285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute subjective effects in LSD- and MDMA-assisted psychotherapy.
    Schmid Y; Gasser P; Oehen P; Liechti ME
    J Psychopharmacol; 2021 Apr; 35(4):362-374. PubMed ID: 33853422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the 5-HT
    Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
    J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence.
    Inserra A; Piot A; De Gregorio D; Gobbi G
    CNS Drugs; 2023 Sep; 37(9):733-754. PubMed ID: 37603260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.
    Schmid Y; Enzler F; Gasser P; Grouzmann E; Preller KH; Vollenweider FX; Brenneisen R; Müller F; Borgwardt S; Liechti ME
    Biol Psychiatry; 2015 Oct; 78(8):544-53. PubMed ID: 25575620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
    Danforth AL; Grob CS; Struble C; Feduccia AA; Walker N; Jerome L; Yazar-Klosinski B; Emerson A
    Psychopharmacology (Berl); 2018 Nov; 235(11):3137-3148. PubMed ID: 30196397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality.
    Dolder PC; Schmid Y; Müller F; Borgwardt S; Liechti ME
    Neuropsychopharmacology; 2016 Oct; 41(11):2638-46. PubMed ID: 27249781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
    Nichols DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.
    Family N; Maillet EL; Williams LTJ; Krediet E; Carhart-Harris RL; Williams TM; Nichols CD; Goble DJ; Raz S
    Psychopharmacology (Berl); 2020 Mar; 237(3):841-853. PubMed ID: 31853557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LSD-assisted psychotherapy in patients with terminal cancer.
    Grof S; Goodman LE; Richards WA; Kurland AA
    Int Pharmacopsychiatry; 1973; 8(3):129-44. PubMed ID: 4140164
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD).
    Beutler BD; Shinozuka K; Tabaac BJ; Arenas A; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e104-e111. PubMed ID: 38518267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.
    Holze F; Vizeli P; Ley L; Müller F; Dolder P; Stocker M; Duthaler U; Varghese N; Eckert A; Borgwardt S; Liechti ME
    Neuropsychopharmacology; 2021 Feb; 46(3):537-544. PubMed ID: 33059356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting subjective effects of LSD in normal subjects.
    Schmid Y; Liechti ME
    Psychopharmacology (Berl); 2018 Feb; 235(2):535-545. PubMed ID: 28918441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
    Ot'alora G M; Grigsby J; Poulter B; Van Derveer JW; Giron SG; Jerome L; Feduccia AA; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    J Psychopharmacol; 2018 Dec; 32(12):1295-1307. PubMed ID: 30371148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.
    Strajhar P; Schmid Y; Liakoni E; Dolder PC; Rentsch KM; Kratschmar DV; Odermatt A; Liechti ME
    J Neuroendocrinol; 2016 Mar; 28(3):12374. PubMed ID: 26849997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
    Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
    J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.